Drugs / PBMC immunomodulated with IFNt
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05775211 | Mar 2023 → Mar 2026 overdue | female infertility | Nadezhda Women's Health Hospital | Recruiting | No outcome recorded |
| — | NCT05775198 | Mar 2023 → Mar 2026 overdue | female infertility | Nadezhda Women's Health Hospital | Recruiting | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBMC immunomodulated with IFNt | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05775211 ↗ |
| Route | Other | “introduced into the uterine cavity via a catheter” NCT05775211 ↗ |